Organoids Created from Stem Cells - Ever Heard of Them?
by Lisa Fritzky, on Aug 13, 2018 4:29:16 PM
Science Fiction Became a Science Reality at the International Society for Stem Cell Research (ISSCR) 2018 Global Conference
The ISSCR is the world’s largest stem cell and regenerative medicine organization and is comprised of stem cell scientists, physicians, and biotechnology leadership. Once a year, ISSCR members meet to collaborate and present on the latest advancements in research, translational medicine (moving research from the laboratories to clinical trials), celebrate patient success stories, and discuss where they see the future of stem cell and regenerative medicine is headed.
This year, the conference included 3,000 attendees from 52 countries and featured over 150 oral presentations from lead researchers from pharmaceutical companies and academic institutes. For a full recap, watch these videos from the conference on next steps for cell and gene therapies, and to understand how models are being built to understand disease and discovery.
Pressed for time? Here’s a breakdown on some of the latest discoveries discussed during the video panels:
- The future is organoids. Novartis Pharmaceuticals is creating “mini brains” using induced pluripotent stem cell (iPS) technology to grow neurons and study neurological diseases. This provides researchers with a human model to understand disease and trial therapies. Click here to read more.
- Vision has been restored for patients with Macular Degeneration after receiving a retinal stem cell therapy in a clinical trial at the University College of London Institute of Ophthalmology. Read this article.
- Patients who have experienced a heart attack will have hope for a heart tissue regeneration therapy that is set to move forward to clinical trials in the next 2-3 years. Research is being done at the Toronto General Hospital Research Institute. Learn more by watching this video: “Next Steps for Cell and Gene Therapies.”
- A stem cell and gene therapy was used to cure a boy who suffered from the terminal skin disorder, epidermolysis bullosa, also known as “butterfly children.” The therapy was developed and trialed at the Center for Regenerative Medicine in Modena in Italy. Access this article.
It’s safe to say, the future applications of stem cells are boundless, and most importantly, the advancements are giving hope to people around the globe who are suffering from progressive or terminal diseases to genetic birth defects.
If you are interested in learning how you can store your stem cells, or offer our adult stem cell banking service to your patients, click here to schedule a consultation with our customer service team.